Can continuous glucose monitoring (CGM) be used on infants and toddlers? Should it be?…
Read More »Adapting the Diabetes Prevention Program for Native American Youth
This study (299-OR) explored ways to modify the Diabetes Prevention Program (DPP) lifestyle change program to make it culturally and age appropriate for Native American youth.…
Read More »Heart Risk Higher in Those Taking Sulfonylurea Drugs vs. Metformin
This retrospective study looking at data from an electronic health record database found that older patients with type 2 diabetes who started treatment with sulfonylurea (SU) drugs were significantly more likely to experience CVD than those who started with metformin….
Read More »GLP-1 Knowledge Survey Part I
Thanks to the great number of you who participated. As we put together the original survey our first thoughts were to find out what you wanted to know about GLP-1 analogs and what your impressions of the class of drugs are…. We asked you “what were the most important things …
Read More »Do Bariatric Surgery Patients Fare Better?
A new study in VA patients has found no survival benefit associated with bariatric surgery among older, severely obese people when compared with usual care, at least out to seven years….
Read More »A Low-Fat Diet May Not Increase Diabetes Risks
A low fat diet has led some doctors to worry that Americans would instead start eating too many carbohydrates but a new study suggests that eating low-fat doesn’t have to increase carbohydrate-fueled health risks….
Read More »Increased Circulating Vitamin D Levels Associated with Weight Loss
Circulating 25-hydroxyvitamin D [25(OH)D] concentrations in postmenopausal women are directly associated with weight loss, whether achieved through lower caloric intake or increased physical activity….
Read More »Experimental TZD Balaglitazone Shows Fewer Side Effects
Balaglitazone, an experimental thiazolidinedione derivative, was slightly less effective than pioglitazone but had fewer side effects in patients with type 2 diabetes in a recent phase III trial.…
Read More »Osteoarthritis Drug Diacerein Improves Glycemic Control in Type 2 Diabetes
In a study, two months of treatment with the anti-inflammatory agent diacerein improved insulin secretion and dropped A1C levels in type 2 diabetes patients from 8.3% to 7.0%, within 60 days.…
Read More »Insulin Resistance Tied to Early Heart Problems
Insulin resistance appears to be an important link between obesity and early adverse cardiac changes in teens….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.